DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP Inhibitors.

Folly-Kossi H, Graves JD, Garan LAW, Lin FT, Lin WC
Cancer Res Commun. 2023 Oct 16;3(10):2096-2112. doi: 10.1158/2767-9764.CRC-23-0166. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.